Agenus Stakeholder Webcast Highlights Reel | Jan 2026 Israel [uBAG8w3e30D]

In this 10-minute highlights reel from Agenus first Stakeholder Webcast of 2026, we share key updates across the BOT+BAL pseb 12th result 2026 program and our priorities for the year ahead.

Highlights include:

Closing of the Zydus partnership to support global manufacturing and operational scale

Rapid expansion of the French AAC BOT+BAL program, extending access for eligible patients

Our 2026 focus: disciplined execution, global access, and operational readiness

Watch to learn how Agenus is advancing its immuno-oncology roadmap and preparing for endrick the next phase of growth.

Video Chapters

00:00 Introduction

1:10 Chapter 1: The CRC Crisis

4:10 Chapter 2: Access is Expanding

7:50 Chapter 3: Scaling Access Responsibly

10:40 furto Closing Statements

Learn more at www.agenusbio.com

#Agenus #BOTBAL #Immunotherapy #Oncology #Biotech